R&D/ Views & Analysis/ Views and analysis Early diagnosis key to future Alzheimer’s treatments mike.hammerton@pharmaphorum.com Aduhelm, Alzheimer's, Alzheimer's Research UK, Biogen, Lilly, RetiSpec 0 Comment The approval of Biogen’s Alzheimer’s treatment could herald a new generation of therapies, but before that can happen, Share X Early diagnosis key to future Alzheimer’s treatments https://pharmaphorum.com/r-d/early-diagnosis-key-to-future-alzheimers-treatments/